OR06 Nuclear Receptors and Co-Regulators in Health and Disease

Program: Abstracts - Orals, Poster Previews, and Posters
Oral Session
Nuclear Receptors and Steroid Hormone Action-Basic/Translational
Friday, April 1, 2016: 11:45 AM-1:15 PM
Room 104 (BCEC)
To Be Determined and Jonna Frasor, PHD, University of Illinois at Chicago, Chicago, IL

Nothing to Disclose: DPM, JF Disclosure Not Provided: JAC, PJL, GEOM
11:45 AM
Somik Chatterjee1, Hongshan Yin2, Ji M Kim1, Zhe Fang3, David L Nelson3 and Ke Ma1, (1)Houston Methodist Research Institute
(2)Third Affiliated Hospital, Hebei Medical University
(3)Baylor College of Medicine
12:15 PM
Jaqueline de Carvalho Rinaldi, PhD1, Wen Yang Hu, PhD1, Shyama Majumdar, PhD2, Dan Ping Hu2, Lishi Xie, PhD1, Timothy Gauntner2, Susan Kasper, PhD3, Luis Antonio Justulin, PhD4 and Gail S. Prins, PhD5, (1)Dept Urology, University of Illinois at Chicago, Chicago, IL
(2)Dept of Urology, University of Illinois at Chicago, Chicago, IL
(3)Dept of Environmental Health, University of Cincinnati, Cincinnati, OH
(4)Dept Morphology, Universidade Estadual Paulista, Botucatu, Brazil
(5)Dept of Urology, University of Illinois-Chicago, Chicago, IL
12:30 PM
Imran Hussain, PhD1, Chien-Cheng Chen, PhD2, Alina Peraza Montalbano, PhD1, Phuong Truong, BS1 and Carole R Mendelson, PhD3, (1)Biochemistry, UT Southwestern Medical Center, Dallas, TX
(2)Urology, UT Southwestern Medical Center, Dallas, TX
(3)Biochemistry and Obstetrics-Gynecology, UT Southwestern Medical Center
12:45 PM
Anna S Garza, University of Texas Medical Branch, Galveston, TX and Raj Kumar, Department of Basic Sciences, The Commonwealth Medical College, Scranton, PA
1:00 PM
Raymond E Soccio, Hee-Woong Lim, Eric R Chen, Joanna R Dispirito, Satyajit R Rajapurkar, Erika R Briggs, Shannon E Mullican, David J Steger, Kyoung Jae Won and Mitchell A Lazar, University of Pennsylvania, Philadelphia, PA


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire